Harm reduction · Pharmacology of N,N-dimethyltryptamine
N,N-dimethyltryptamine (DMT) is one of the most thoroughly studied classic psychedelics and, at the same time, one of the least well understood in practice. It is an agonist at serotonin 5-HT2A receptors, with affinity also for other serotonin receptors, for sigma-1 receptors and for the TAAR1 receptor. It occurs naturally in many plants and, in trace amounts, in mammalian tissue. Its most relevant pharmacological feature for the person taking it is not its potency but its metabolic fragility: orally it is inactive, because intestinal and hepatic monoamine oxidase A (MAO-A) breaks it down before it can reach the brain.
That fact shapes every discussion of routes of administration. There are two ways around MAO-A: bypass first-pass metabolism (inhalation, injection) or inhibit the enzyme (ayahuasca and its analogues). This article examines the first strategy in its usual variants and combines it with the second, something the psychonaut community calls vaporhuasca. It is written from a harm-reduction perspective: it neither promotes nor condemns use, and starts from the premise that people who do this deserve rigorous information.
The inhaled route: why it is so brief and intense
When DMT is vaporised and inhaled, it crosses the alveolar-capillary membrane within seconds and enters the arterial circulation, which carries it to the brain without passing through the liver first. Onset is almost immediate and the peak arrives within one to two minutes. MAO-A (present in the liver, gut, lung, blood vessels and brain) then degrades it, with a plasma half-life of only a few minutes; in Strassman’s classic intravenous studies the whole experience lasted around twenty to thirty minutes, with the intense part concentrated in the first ten1.
The practical consequence is a “spike and fall” curve: an immersive experience, often described as a total break with the surroundings (breakthrough), followed by a rapid return. That speed is a safety advantage (the person is back soon) but also a drawback for integration, and it encourages repeat dosing, which is the behaviour most worth watching.
Combustion versus vaporisation
DMT as the free base (the amber or off-white crystal sold as “DMT”) melts at about 45-50 °C and volatilises below the combustion temperature of plant material. That thermal window is the key to everything that follows: the aim is to evaporate the molecule without burning either it or its carrier. As an indicative order of magnitude, effective vaporisation takes place in the range of 150 to 200 °C; above that, degradation and irritant by-products increase.
Smoking involves combustion, and combustion has a cost for the lung and for the dose. More than carbon dioxide (which merely dilutes the inhaled air), the problems are carbon monoxide, which binds to haemoglobin with far greater affinity than oxygen, tar, particulates and polycyclic aromatic hydrocarbons. Moreover, at flame temperatures part of the alkaloid is pyrolysed and another part is lost in sidestream smoke, so the effective dose is lower and unpredictable. In terms of respiratory health and dosing, temperature-controlled vaporisation is clearly superior.
The options in detail
Changa
Changa is a herbal blend (mint, passionflower, mullein, blue lotus, caapi leaf and others) impregnated with DMT and smoked in a pipe. Its appeal is ease of use and an experience somewhat softer and more gradual than that of the pure crystal. Its limitations are those of any combustion: loss of active compound, bronchial irritation and, above all, imprecise dosing, since each puff contains an unknown amount of alkaloid. The role of caapi leaf or other harmala sources as an MAO inhibitor is often invoked; in practice, the amount of harmine or harmaline reaching the body with a few puffs is small, and there is no controlled evidence that it achieves MAO-A inhibition comparable to an oral dose. The slightly longer effect some people report may owe to other factors.
Vaporiser with pure DMT
This is the most efficient option in terms of dose and the cleanest for the lung: glass or temperature-controlled devices that heat the crystal without a direct flame. It allows the dose to be weighed, conditions to be repeated and smoke to be reduced. It requires suitable equipment, attention to temperature and a reliable measurement (a 0.001 g scale), and demands one basic rule: a single inhalation, then wait before deciding anything further.
Vape cartridges and pens
Cartridges with DMT dissolved in propylene glycol, glycerine or other vehicles are convenient but accumulate uncertainties: the real concentration, the stability of DMT in solution, additives and how the vehicle behaves when heated. The 2019 vaping-associated lung injury outbreak (EVALI), linked to vitamin E acetate in adulterated cannabis cartridges, is a reminder that inhaling an oil or an additive of unknown composition is not harmless. Avoid any oily vehicle and be wary of commercial products that have not been analysed. In Spain, Energy Control’s substance-testing service lets you find out what a sample really contains before using it.
Vaporhuasca: oral MAO inhibitor + inhaled DMT
Classic ayahuasca combines a DMT source (Psychotria viridis, Mimosa hostilis and similar) with an MAO inhibitor, traditionally the vine Banisteriopsis caapi. The β-carboline alkaloids of caapi (harmine, tetrahydroharmine and, in smaller proportion, harmaline) are reversible inhibitors of MAO-A (RIMAs). Syrian rue (Peganum harmala, not to be confused with common rue, Ruta graveolens) contains harmine and harmaline in high proportion in its seeds and serves the same function at a much lower cost than caapi.
Vaporhuasca transfers that logic to the inhaled route. The scheme is simple: the β-carboline source is taken orally and one waits about 40-50 minutes, the time needed for enzyme inhibition to take effect; the DMT is then inhaled. With MAO-A inhibited, inhaled DMT no longer breaks down within minutes. The experience becomes longer, deeper and more bodily, with a curve closer to that of ayahuasca than to plain smoked DMT. Those who practise it speak of a qualitative leap, and it is not hard to see why: it combines the instant entry of the pulmonary route with the metabolic persistence of the potentiated oral route, something Jonathan Ott described in the pharmacological literature when studying oral DMT with harmine (pharmahuasca)2.
From an efficiency standpoint it is probably the most cost-effective combination: β-carbolines are cheap, less DMT is needed for the same subjective effect, each milligram of the alkaloid (the expensive part) is better used, and the losses associated with combustion are avoided. But “efficient” does not mean “simple”: it is also the route with the greatest potential for surprise.
Comparison
| Option | Advantages | Drawbacks |
|---|---|---|
| Changa | Easy, gradual, ritual | Combustion, uncertain dose, loss of alkaloid |
| Vaporiser, pure DMT | Controllable dose, lower lung burden | Needs equipment and reliable weighing; very fast peak |
| Vape cartridges | Convenience | Unknown concentration and additives |
| Vaporhuasca | Cost and yield; longer, deeper experience; less DMT | Serious interactions, nausea and vomiting, less predictable duration and intensity |
Specific risks of vaporhuasca
Drug interactions. This is the main risk. An MAO-A inhibitor combined with serotonergic drugs can cause serotonin syndrome, a medical emergency. Incompatible substances include, among others, SSRIs and SNRIs, tricyclic antidepressants, tramadol, pethidine, dextromethorphan, MDMA, amphetamines and other stimulants, triptans, St John’s wort and 5-HTP. Many antidepressants require weeks of washout, which must never be done on one’s own: it is agreed with the prescribing doctor. Reversible MAO-A inhibition lasts several hours, and while it lasts no other substances should be taken.
Blood pressure and tyramine. β-carbolines raise blood pressure and heart rate. With a RIMA the risk of a tyramine-induced hypertensive crisis is considerably lower than with the classic irreversible inhibitors, but it is not zero; hence the traditional ayahuasca diet (avoiding aged cheeses, cured meats, fermented foods and broad beans) and the precautions for people with hypertension, heart disease or liver disease.
Effects of the harmala itself. Harmaline is psychoactive in its own right and causes tremor, dizziness, drowsiness and nausea. Vomiting is common and, combined with deep disorientation, carries a risk of aspiration: the person should be seated or lying on their side, with a bucket nearby, and never alone. Raising the harmala dose does not improve the result beyond what is needed to inhibit the enzyme, and it worsens tolerability.
Dose and duration. With MAO-A inhibited, the usual dose of inhaled DMT stops being usual: the prudent course is to start with a fraction, a single inhalation, and wait. The experience can last considerably longer than usual and offers no way back. Anyone who has never tried the combination should not calculate the dose by analogy with what they know of smoked DMT.
Other tryptamines. Never combine an MAOI with 5-MeO-DMT or bufotenine: the mixture is far less predictable and serious reactions have been described.
Minimum safety protocol
- A sober companion who does not use, knows the plan and can act. Never alone.
- Seated or lying down, in a safe, soft place, with no glassware within reach during the intense phase. The companion holds the device; hot glass and metal cause serious burns.
- One inhalation, pause, assessment. Do not chain doses during the peak. Avoid holding the breath for too long: syncope from prolonged apnoea is an avoidable cause of falls and injury.
- Review medication and history first. Relevant contraindications: serotonergic drugs, uncontrolled hypertension, heart disease, liver disease, pregnancy, and personal or family history of psychosis or bipolar disorder.
- No alcohol or other substances, and a light fast beforehand (it also reduces nausea).
- Test the substance whenever its origin is in doubt.
- Make time for integration: an experience of this kind is not resolved the moment it ends. Do not drive or take on responsibilities for the rest of the day.
Legal framework
DMT is listed in Schedule I of the 1971 Vienna Convention on Psychotropic Substances, and its possession or trafficking is prosecuted in Spain; the plants that contain it and those that contain β-carbolines are not controlled as such, but using them to extract or prepare the substance enters complex legal territory. This is general information, not legal advice.
Conclusion
The inhaled route solves DMT’s metabolic problem; vaporisation does so with less harm than combustion; and reversible MAO-A inhibition with Syrian rue or caapi turns a brief experience into a longer, deeper one that is also cheaper per unit of effect. Each step adds power and also risk: of interactions, of intensity, of duration and of loss of control. Harm reduction does not consist of forbidding that staircase, but of knowing each step, climbing slowly and not doing it without company or without having reviewed one’s medication.
Further reading
- Strassman RJ, Qualls CR. Dose-response study of N,N-dimethyltryptamine in humans. Arch Gen Psychiatry. 1994;51(2):85-97.
- Ott J. Pharmahuasca: human pharmacology of oral DMT plus harmine. J Psychoactive Drugs. 1999;31(2):171-177.
- Riba J, Valle M, Urbano G, et al. Human pharmacology of ayahuasca: subjective and cardiovascular effects, monoamine metabolite excretion, and pharmacokinetics. J Pharmacol Exp Ther. 2003;306(1):73-83.
- McKenna DJ, Towers GHN, Abbott F. Monoamine oxidase inhibitors in South American hallucinogenic plants: tryptamine and β-carboline constituents of ayahuasca. J Ethnopharmacol. 1984;10(2):195-223.
This article is for information and harm-reduction purposes. It does not replace medical advice. If you are on medication, consult your doctor before combining any substance with MAO inhibitors.


